Oxford, United Kingdom

Quentin Chometon

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Optellum Limited. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Quentin Chometon

Introduction

Quentin Chometon is a notable inventor based in Oxford, GB. He has made significant strides in the field of medical technology, particularly in the area of lung cancer diagnosis. His work focuses on enhancing the way medical scan images are displayed and analyzed, which is crucial for accurate diagnosis and treatment.

Latest Patents

Quentin Chometon holds a patent for a "Method and apparatus for displaying and analyzing medical scan images." This innovative display system is designed for a computer-aided lung cancer diagnosis system. The system features a user interface that includes a patient information display, an image display for medical images, and a patient timeline display. Additionally, it incorporates a proxy data store to manage selected medical images, ensuring that only relevant images are presented to healthcare professionals.

Career Highlights

Chometon is currently associated with Optellum Limited, a company that focuses on developing advanced technologies for lung cancer diagnosis and treatment. His contributions to the field have been instrumental in improving diagnostic accuracy and patient care.

Collaborations

Throughout his career, Quentin has collaborated with talented individuals such as David Arrowsmith and Timor Kadir. These partnerships have fostered innovation and have been vital in the development of cutting-edge medical technologies.

Conclusion

Quentin Chometon's work exemplifies the impact of innovation in the medical field. His patent and contributions to Optellum Limited highlight the importance of technology in enhancing healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…